Announcement on Resignation and Election of Director
Filed with SSE · · 3 pages · Chinese
China National Medicines Corporation Ltd. on 6ix
Earlier from China National Medicines
- Announcement on Convening the Q3 2024 Performance Briefing
- Indicative Announcement on Change in Equity of Shareholder with Shareholding Ratio Reaching 5%
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2024
- Announcement on Resolution of the 19th Meeting of the 8th Board of Directors
- Investor Relations Activity Record Form
Later from China National Medicines
- Announcement on Resolution of the 4th Extraordinary General Meeting in 2024
- Announcement on Resolution of the 17th Meeting of the 8th Board of Supervisors
- Announcement on Returning the Raised Funds Temporarily Used for Supplementing Current Capital in Advance
- Announcement on "Corporate Value and Return Enhancement" Action Plan
- Announcement on the Proposed Using Partial Idle Raised Funds to Temporarily Supplement Current Capital
Follow China National Medicines into a list and get an email when it puts out news.
Follow China National Medicines